BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Drug Development

  KOSAN Biosciences, Inc. Cancer Drug Shows Lower Response Rate, Shares Fall

  December 10, 2007

   · 

  9 min read
• BioForest

  Advanced Medical Isotopes Corporation Assists in Remedy of Critical Shortage of Medical Isotopes

  December 10, 2007

   · 

  1 min read
• Labopharm to present at RBC Capital Markets 2007 Healthcare Conference

  December 10, 2007

   · 

  2 min read
• Drug Development

  Immunomedics, Inc. Reports Advances in Cancer Therapy

  December 10, 2007

   · 

  1 min read
• Bradmer Pharmaceuticals Inc. to Participate in Panel Presentation at RBC Capital Markets Healthcare Conference

  December 10, 2007

   · 

  2 min read
• Drug Development

  Johnson & Johnson: Pivotal Phase III Data Showed Rivaroxaban Was Statistically Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE) in Patients Following Hip Replacement Surgery

  December 10, 2007

   · 

  1 min read
• Policy

  Mealey’s™ Merck & Co., Inc.'s VIOXX® Settlement Conference: A Plaintiff Bar Discussion & Roundtable to be held Dec. 10 in New Orleans

  December 10, 2007

   · 

  1 min read
• Drug Development

  Pharmion Corporation and MethylGene Report Favorable Results for Phase 2 MGCD0103 Single Agent Studies

  December 10, 2007

   · 

  10 min read
• Drug Development

  Micromet and MedImmune, Inc. Present New Clinical Data for MT103

  December 10, 2007

   · 

  9 min read
• Drug Development

  Amgen’s Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints

  December 10, 2007

   · 

  12 min read